These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26232129)

  • 21. Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer.
    Chung H; Polf J; Badiyan S; Biagioli M; Fernandez D; Latifi K; Wilder R; Mehta M; Chuong M
    J Appl Clin Med Phys; 2017 Jan; 18(1):32-39. PubMed ID: 28291917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.
    Chapet O; Udrescu C; Devonec M; Tanguy R; Sotton MP; Enachescu C; Colombel M; Azria D; Jalade P; Ruffion A
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):72-6. PubMed ID: 23290444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.
    Leiker AJ; Desai NB; Folkert MR
    Future Oncol; 2018 Nov; 14(26):2773-2788. PubMed ID: 29939069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study.
    Melchert C; Gez E; Bohlen G; Scarzello G; Koziol I; Anscher M; Cytron S; Paz A; Torre T; Bassignani M; Dal Moro F; Jocham D; Yosef RB; Corn BW; Kovács G
    Radiother Oncol; 2013 Feb; 106(2):210-4. PubMed ID: 23484879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M; Lebesque JV; Mijnheer BJ; Damen EM
    Radiother Oncol; 2004 Nov; 73(2):209-18. PubMed ID: 15542168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FEMOSSA: Patient-specific finite element simulation of the prostate-rectum spacer placement, a predictive model for prostate cancer radiotherapy.
    Hooshangnejad H; Youssefian S; Guest JK; Ding K
    Med Phys; 2021 Jul; 48(7):3438-3452. PubMed ID: 34021606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk.
    Vanneste BGL; van Wijk Y; Lutgens LC; Van Limbergen EJ; van Lin EN; van de Beek K; Lambin P; Hoffmann AL
    Strahlenther Onkol; 2018 Jan; 194(1):31-40. PubMed ID: 29038832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectiveness.
    van Wijk Y; Vanneste BGL; Walsh S; van der Meer S; Ramaekers B; van Elmpt W; Pinkawa M; Lambin P
    Radiother Oncol; 2017 Oct; 125(1):107-112. PubMed ID: 28823404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible?
    Amini A; Westerly DC; Waxweiler TV; Ryan N; Raben D
    Med Dosim; 2015; 40(3):256-61. PubMed ID: 25824420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A review.
    Sanei M; Ghaffari H; Ardekani MA; Mahdavi SR; Mofid B; Abdollahi H; Rostami A
    J Cancer Res Ther; 2021; 17(2):303-310. PubMed ID: 34121672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of rectal sparing throughout the course of proton therapy treatment in prostate cancer patients treated with SpaceOAR
    Hedrick SG; Fagundes M; Case S; Renegar J; Blakey M; Artz M; Chen H; Robison B; Schreuder N
    J Appl Clin Med Phys; 2017 Jan; 18(1):82-89. PubMed ID: 28291933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
    Mott JH; Livsey JE; Logue JP
    Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.
    Nguyen PL; Devlin PM; Beard CJ; Orio PF; O'Leary MP; Wolfsberger LD; O'Farrell DA; Sweeney CM; Hadaschik BA; Hohenfellner M; Hatiboglu G
    Brachytherapy; 2013; 12(1):77-83. PubMed ID: 22543116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.
    Padmanabhan R; Pinkawa M; Song DY
    Future Oncol; 2017 Dec; 13(29):2697-2708. PubMed ID: 29168659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.